Literature DB >> 32560071

COVID-19 Infection Fatality Rate Associated with Incidence-A Population-Level Analysis of 19 Spanish Autonomous Communities.

Chris Kenyon1,2.   

Abstract

Previous studies have found large variations in the COVID-19 infection fatality rate (IFR). This study hypothesized that IFR would be influenced by COVID-19 epidemic intensity. We tested the association between epidemic intensity and IFR using serological results from a recent large SARS-CoV-2 serosurvey (N = 60,983) in 19 Spanish regions. The infection fatality rate for Spain as a whole was 1.15% and varied between 0.13% and 3.25% in the regions (median 1.07%, IQR 0.69-1.32%). The IFR by region was positively associated with SARS-CoV-2 seroprevalence (rho = 0.54; p = 0.0162), cases/100,000 (rho = 0.75; p = 0.002), hospitalizations/100,000 (rho = 0.78; p = 0.0001), mortality/100,000 (rho = 0.77; p = 0.0001) and case fatality rate (rho = 0.49; p = 0.0327). These results suggest that the SARS-CoV-2 IFR is not fixed. The Spanish regions with more rapid and extensive spread of SARS-CoV-2 had higher IFRs. These findings are compatible with the theory that slowing the spread of COVID-19 down reduces the IFR and case fatality rate via preventing hospitals from being overrun, and thus allowing better and lifesaving care.

Entities:  

Keywords:  COVID-19; SARS CoV-2; case fatality rate; epidemiology; infection fatality rate

Year:  2020        PMID: 32560071     DOI: 10.3390/biology9060128

Source DB:  PubMed          Journal:  Biology (Basel)        ISSN: 2079-7737


  6 in total

1.  Beyond comorbidities, sex and age have no effect on COVID-19 health care demand.

Authors:  Jorge M Mendes; Helena Baptista; André Oliveira; Bruno Jardim; Miguel de Castro Neto
Journal:  Sci Rep       Date:  2022-05-05       Impact factor: 4.996

2.  Immunological Evaluation on Potential Treatment Window for Hospitalized COVID-19 Patients.

Authors:  Jing Yuan; Shanglong Kou; Yanhua Liang; JianFeng Lan; Xiaohe Li; Lijiao Zeng; Rongrong Zou; Yingxia Liu; Lei Liu; Yanchao Pan
Journal:  J Inflamm Res       Date:  2020-11-24

3.  A parsimonious approach for spatial transmission and heterogeneity in the COVID-19 propagation.

Authors:  L Roques; O Bonnefon; V Baudrot; S Soubeyrand; H Berestycki
Journal:  R Soc Open Sci       Date:  2020-12-15       Impact factor: 2.963

4.  Analysis of case fatality rate of SARS-CoV-2 infection in the Spanish Autonomous Communities between March and May 2020.

Authors:  Martín-Sánchez V; Calderón-Montero A; Barquilla-García A; Vitelli-Storelli F; Segura-Fragoso A; Olmo-Quintana V; Serrano-Cumplido A
Journal:  PLoS One       Date:  2021-12-03       Impact factor: 3.240

Review 5.  COVID-19: a review of current knowledge regarding exposure, quarantine, isolation and other preventive measures.

Authors:  Robert Rosolanka; Andres F Henao-Martinez; Larissa Pisney; Carlos Franco-Paredes; Martin Krsak
Journal:  Ther Adv Infect Dis       Date:  2021-07-14

6.  Immunomodulation as Treatment for Severe Coronavirus Disease 2019: A Systematic Review of Current Modalities and Future Directions.

Authors:  Eric A Meyerowitz; Pritha Sen; Sara R Schoenfeld; Tomas G Neilan; Matthew J Frigault; John H Stone; Arthur Y Kim; Michael K Mansour
Journal:  Clin Infect Dis       Date:  2021-06-15       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.